Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -2015/16 group results

May 9 (Reuters)-  
          Takara Bio Inc.  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2016    Mar 31, 2015   Mar 31, 2017     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales           29.73           25.97          31.00        14.11     
               (+14.5 pct)     (+8.6 pct)     (+4.3 pct)    (+6.4 pct)  
  Operating        2.67            2.30           2.70       744 mln    
               (+15.8 pct)     (+17.8 pct)    (+1.2 pct)    (+8.8 pct)  
  Recurring        3.30            2.77           3.05       844 mln    
               (+19.1 pct)     (+23.8 pct)    (-7.6 pct)    (-2.7 pct)  
  Net 
  Net              1.33          963 mln          1.30        68 mln    
               (+38.4 pct)     (-34.4 pct)    (-2.6 pct)   (-52.6 pct)  
  EPS           11.08 yen       8.01 yen       10.80 yen     0.57 yen   
  Ann Div       1.80 yen        1.50 yen       1.80 yen                 
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div       1.80 yen        1.50 yen       1.80 yen                 
   
  NOTE - Takara Bio Inc.. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Takara Bio

See all news